000 01499 a2200409 4500
005 20250515233232.0
264 0 _c20110111
008 201101s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.00368-10
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLin, Kun-Hsien
245 0 0 _aIn vivo protection provided by a synthetic new alpha-galactosyl ceramide analog against bacterial and viral infections in murine models.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cOct 2010
300 _a4129-36 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnti-Bacterial Agents
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aGalactosylceramides
_xadministration & dosage
650 0 4 _aGram-Negative Bacterial Infections
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aSphingomonas
_xdrug effects
650 0 4 _aStaphylococcus aureus
_xdrug effects
700 1 _aLiang, Jian-Jong
700 1 _aHuang, Wen-I
700 1 _aLin-Chu, Shao-Ying
700 1 _aSu, Ching-Yao
700 1 _aLee, Yi-Ling
700 1 _aJan, Jia-Tsong
700 1 _aLin, Yi-Ling
700 1 _aCheng, Yih-Shyun E
700 1 _aWong, Chi-Huey
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 54
_gno. 10
_gp. 4129-36
856 4 0 _uhttps://doi.org/10.1128/AAC.00368-10
_zAvailable from publisher's website
999 _c20000798
_d20000798